Journal of Microencapsulation

Papers
(The H4-Index of Journal of Microencapsulation is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Applications of propolis encapsulation in food products45
Fabrication of moxifloxacin HCl-loaded biodegradable chitosan nanoparticles for potential antibacterial and accelerated cutaneous wound healing efficacy41
β-Cyclodextrin-functionalized nanocarriers for bromocriptine: development, evaluation and histopathological studies37
Development, systematic optimisation and biofilm disruption activity of eugenol-based nanosized emulsions stabilised with Tween 8028
Advancements in microneedle technology: current status and next-generation innovations27
Her-2 nanobody modified cisplatin nanoparticles for precise chemotherapy of colon cancer26
Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex: preparation and characterisation. Analytical validation for metal determination by microwave-induced 24
The pH-controlled release properties of chitosan–gold nanoparticles encapsulated nobiletin to induce apoptosis through PI3K/AKT/mTOR signalling pathway on gastric cancer cell lines22
Recent developments in sustained-release and targeted drug delivery applications of solid lipid nanoparticles21
Impregnation of polyethylene terephthalate (PET) grafts with BMP-2 loaded functional nanoparticles for reconstruction of anterior cruciate ligament20
Synergistic effect of DR5-targeted capsules loaded with doxorubicin in drug-resistant 3D tumour spheroids18
Encapsulation of Ruta essential oil in chitosan and alginate matrices as an ecological alternative for the control of nematodes16
Chitooligosaccharide-catechin conjugate loaded liposome using different stabilising agents: characteristics, stability, and bioactivities14
Ethosome as antigen delivery carrier: optimisation, evaluation and induction of immunological response via nasal route against hepatitis B14
0.16351699829102